MDK and hepatocellular carcinoma: MDK can be utilized as a novel biomarker for hepatocellular carcinoma (HCC) to enhance early diagnosis accuracy and as a potential target for clinical therapy (Tsuchiya et al., 2015; Darmadi, Ruslie & Pakpahan, 2022; Zhang et al., 2020).